In recent years, medications designed for type 2 diabetes have gained attention for their weight loss benefits. Two such drugs, Trulicity (dulaglutide) and Mounjaro (tirzepatide), are often compared due to their effects on weight reduction.
While both were initially developed to help with blood sugar control, they have also shown significant potential for weight loss. Understanding the key differences between these medications can help you and your doctor choose the right option for your goals.
This guide breaks down the differences between Trulicity and Mounjaro, including their effectiveness, dosage, side effects, and safety considerations. Whether you’re exploring how tirzepatide works or weighing your GLP-1 options, you’ll find the evidence-based answers you need below.
Explore Your Weight Loss Options
Get a personalized consultation with our board-certified providers to find the right GLP-1 medication for your weight loss and health goals.
Book Your Consultation Free consultation • No pressure • Personalized treatment planIn This Guide
What Are Trulicity and Mounjaro?
Trulicity (Dulaglutide)
Trulicity is a GLP-1 receptor agonist that works by increasing insulin secretion, slowing digestion, and reducing appetite. It was approved by the FDA for type 2 diabetes and has also been found to help with weight loss in some patients. If you’re familiar with other medications in this class, you may want to compare it with options like Wegovy vs Ozempic.
Mounjaro (Tirzepatide)
Mounjaro is a newer drug that targets two receptors: GLP-1 and GIP. This dual-action approach helps control blood sugar while also significantly affecting weight. Mounjaro is currently approved for diabetes and has shown strong potential for weight loss. Learn more about how tirzepatide works at the molecular level.
Trulicity targets one receptor (GLP-1), while Mounjaro targets two receptors (GLP-1 and GIP). This dual-action mechanism is what gives Mounjaro its stronger weight loss effects.
Which One Works Better for Weight Loss?
Trulicity for Weight Loss
Clinical studies have found that Trulicity users lose an average of 3.1 kg (6.8 lbs) over six months on a standard 1.5 mg dose. When higher doses (3.0 mg and 4.5 mg) were tested, weight loss increased to 4.1 kg (9 lbs) and 4.7 kg (10.4 lbs) over nine months.
Mounjaro for Weight Loss
Mounjaro has shown much greater weight loss effects. Clinical trials found that people on Mounjaro lost between 8% and 14% of their body weight over a year. In studies involving people without diabetes, weight loss ranged from 15% to nearly 21% over 16 months. If you’re struggling with results on a similar medication, check out our guide on why you may not be losing weight on Mounjaro.
Comparison of Results
- Trulicity: Helps with moderate weight loss but is primarily designed for diabetes management.
- Mounjaro: Leads to greater weight loss due to its dual-receptor mechanism.
If weight loss is the main goal, Mounjaro appears to be the more effective option. Supporting your medication with the right nutrition, including the best vitamins for weight loss, can also enhance your results.
Dosage and Administration
Trulicity Dosage
- Injected once per week under the skin.
- Starting dose: 0.75 mg, which may increase to 1.5 mg, 3.0 mg, or 4.5 mg based on response.
Mounjaro Dosage
- Also injected once per week.
- Starts at 2.5 mg, increasing to 5 mg after four weeks, with further increases up to 15 mg as needed.
Mounjaro offers more flexibility in dosing, allowing higher amounts for those needing stronger effects.
Side Effects and Risks
Both drugs can cause gastrointestinal issues such as:
- Nausea
- Vomiting
- Diarrhea
- Decreased appetite
These side effects are usually temporary and improve over time. For a deeper look at what to expect, read about Mounjaro side effects and how long semaglutide side effects last.
Serious Risks
- Both medications carry an FDA warning about a possible risk of thyroid cancer, though this has only been seen in animal studies.
- They are not recommended for people with a family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
- Always discuss your complete medical history with your provider before starting either medication.
Get Expert Guidance on GLP-1 Medications
Our medical team can help you understand which medication is right for your body, health history, and weight loss goals.
Schedule Your Consultation Board-certified providers • Baltimore, MDApprovals and Off-Label Use
Trulicity Approval
- Approved for type 2 diabetes
- Approved for reducing cardiovascular risks in some patients
Mounjaro Approval
- Approved for type 2 diabetes
- It is not yet approved for weight loss, but it is expected to receive approval soon
Even though Mounjaro is not officially approved for weight loss, doctors often prescribe it off-label for this purpose. This is a common practice with GLP-1 medications, similar to how other drugs in this class have been used. For more on weight loss medications, explore our comparison of Wegovy vs Ozempic.
Which One Should You Choose?
| Feature | Trulicity (Dulaglutide) | Mounjaro (Tirzepatide) |
|---|---|---|
| Drug Type | GLP-1 receptor agonist | Dual GLP-1 & GIP agonist |
| FDA Approval | Type 2 Diabetes, Cardiovascular Risk Reduction | Type 2 Diabetes (Weight loss approval pending) |
| Weight Loss | 6.8–10.4 lbs over 6–9 months | 8%–21% of body weight over 12–16 months |
| Dosage | Weekly injection (0.75 mg–4.5 mg) | Weekly injection (2.5 mg–15 mg) |
| Effectiveness | Moderate | High |
| Side Effects | Nausea, vomiting, diarrhea, decreased appetite | Nausea, vomiting, diarrhea, decreased appetite |
| Serious Risks | Possible thyroid cancer risk (animal studies) | Possible thyroid cancer risk (animal studies) |
| Best For | Moderate weight loss + diabetes control | Significant weight loss + diabetes control |
- For moderate weight loss: Trulicity may be a good option, especially if you are also managing diabetes.
- For significant weight loss: Mounjaro is more effective, especially at higher doses.
It is always best to consult a doctor before starting either medication. Your provider can evaluate your health history, current medications, and weight loss goals to recommend the best approach. You may also want to explore complementary treatments like peptides for muscle growth to support body composition during your weight loss journey.
Final Thoughts
Trulicity and Mounjaro both offer weight loss benefits, but Mounjaro has shown stronger effects in clinical trials. If weight loss is a top priority, Mounjaro may be the better choice. However, Trulicity remains a solid option for those looking for a more moderate effect combined with strong diabetes management.
The right choice depends on your individual health profile, weight loss goals, and how your body responds to treatment. Working with an experienced medical provider ensures you get personalized guidance throughout your weight loss journey.
Mounjaro offers superior weight loss results due to its dual-receptor mechanism, while Trulicity provides steady, moderate weight loss with proven cardiovascular benefits. Both are effective tools when combined with lifestyle changes and medical supervision.
Start Your Weight Loss Journey Today
Book a consultation with our board-certified team to discuss whether Trulicity, Mounjaro, or another GLP-1 medication is the right fit for your goals.
Book Your Consultation Green Relief Health • Baltimore, MD • (410) 368-0420Frequently Asked Questions
Both medications were originally developed for type 2 diabetes. Trulicity is FDA-approved only for diabetes and cardiovascular risk reduction. Mounjaro is approved for diabetes, with weight loss approval expected soon. However, doctors frequently prescribe both off-label for weight management in appropriate patients. Always consult your healthcare provider to determine if either medication is suitable for your weight loss goals.
Clinical studies show Trulicity users lose an average of 6.8 to 10.4 lbs over 6 to 9 months, depending on the dose. Mounjaro users have experienced significantly more weight loss, ranging from 8% to 21% of their total body weight over 12 to 16 months. Individual results vary based on dosage, diet, exercise, and overall health.
Both Trulicity and Mounjaro share similar gastrointestinal side effects, including nausea, vomiting, diarrhea, and decreased appetite. These effects are usually most noticeable when starting the medication or increasing the dose. They tend to improve over time as your body adjusts. Starting at a lower dose and gradually increasing helps minimize these side effects.
Both medications are administered as a once-weekly subcutaneous injection. They come in pre-filled pens that are easy to use at home. You should inject on the same day each week, though the time of day can vary. Common injection sites include the abdomen, thigh, or upper arm.
Yes, switching from Trulicity to Mounjaro is possible under medical supervision. Your doctor will typically have you stop Trulicity and start Mounjaro at the initial 2.5 mg dose, gradually titrating up. The transition should be managed by your healthcare provider to ensure proper dosing and to monitor for any adverse effects.
Both medications carry an FDA boxed warning about a potential risk of thyroid C-cell tumors, including medullary thyroid carcinoma, which has been observed in animal studies. They are not recommended for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Discuss your complete medical history with your provider before starting either medication.
